ロード中...
Efficacy and safety of anti-PD-1/anti-PD-L1 antibody therapy in treatment of advanced gastric cancer or gastroesophageal junction cancer: A meta-analysis
BACKGROUND: Faced with limited and inadequate treatment options for patients with advanced gastric cancer or gastroesophageal junction cancer (GC/GEJC), researchers have turned toward, with the support of promising clinical trials, anti-PD-1/anti-PD-L1 antibody therapy. But there are also different...
保存先:
| 出版年: | World J Gastrointest Oncol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Inc
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7667450/ https://ncbi.nlm.nih.gov/pubmed/33250966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v12.i11.1346 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|